SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003160
Filing Date
2021-11-05
Accepted
2021-11-05 07:57:06
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alvr-20210930.htm   iXBRL 10-Q 2869396
2 EX-31.1 alvr-ex31_1.htm EX-31.1 17347
3 EX-31.2 alvr-ex31_2.htm EX-31.2 17382
4 EX-32.1 alvr-ex32_1.htm EX-32.1 10469
5 EX-32.2 alvr-ex32_2.htm EX-32.2 10507
  Complete submission text file 0000950170-21-003160.txt   8410114

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alvr-20210930_pre.xml EX-101.PRE 306361
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alvr-20210930_def.xml EX-101.DEF 159863
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alvr-20210930.xsd EX-101.SCH 55136
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alvr-20210930_lab.xml EX-101.LAB 442066
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alvr-20210930_cal.xml EX-101.CAL 39276
11 EXTRACTED XBRL INSTANCE DOCUMENT alvr-20210930_htm.xml XML 1329743
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39409 | Film No.: 211382366
SIC: 2836 Biological Products, (No Diagnostic Substances)